Arkolith/Insider Trading/AXSM/Form 4

Tabuteau Herriot

Chief Executive Officer, Director, 10% OwnerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11.9M
Net Open-Market Flow
-$11.9M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)50K$4.95$246K57K
Jul 1, 2026Sell(S)50K$240.25$11.9M7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)50K—$050K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-292985) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML